• Zheng Han, Yajuan Li, Sarah Roelle, Zhuxian Zhou, Yuchi Liu, Rob Sabatelle, Aidan DeSanto, Xin Yu, Hui Zhu, Cristina Magi-Galluzzi, and Zheng-Rong Lu. A Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI, Bioconjugate Chem. 2017, 28, 1031-1040. 

 

• Wu X, Yu G, Lindner D, Brady-Kalnay SM, Zhang Q, Lu ZR. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI. Am J Nucl Med Mol Imaging. 2014, 4, 525-36. 

 

• Yajuan Li, Zheng Han, Sarah Roelle, Aidan DeSanto, Rob Sabatelle, Rebecca Schur, and Zheng-Rong Lu. Synthesis and Assessment of Peptide Gd–DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer, Molecular Pharmaceutics. 2017 14 (11), 3906-3915

 

• Zheng Han, Zhuxian Zhou, Xiaoyue Shi, Junpeng Wang, Xiaohui Wu, Da Sun, Yinghua Chen, Hui Zhu, Cristina Magi-Galluzzi, and Zheng-Rong Lu. An EDB fibronectin specific peptide for prostate cancer targeting. Bioconjugate Chem. 2015, 26, 830-838. 

 

• Zhuxian Zhou, Mohammed Qutaish, Zheng Han, Rebecca M. Schur, Yiqiao Liu, David L. Wilson, Zheng-Rong Lu. MRI Detection of Breast Cancer Micrometastases with a fibronectin targeting contrast agent. Nature Commun. 2015, 6, 7984. 

 

• Han Z, Wu X, Roelle S, Chen C, Schiemann WP, Lu ZR. Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer. Nature communications. 2017 Sep 25.